Clement Kabakama1*, Abdul Rafey Usmani2 and Zahra D Khan3
1Department of Internal Medicine, Muhimbili University of Health and Allied Sciences, Tanzania
2Department of Pediatric, University of Dodoma Teaching Hospital, Tanzania
3Department of Cardiology, TMJ Multi Speciality Hospital, Tanzania
*Corresponding Author: Clement Kabakama, Department of Internal Medicine, Muhimbili University of Health and Allied Sciences, Tanzania.
Received: July 12, 2021; Published: July 28, 2021
Rheumatic Heart Disease (RHD) is an autoimmune response to group A-streptococcus infections of the upper respiratory tract which may result in carditis or inflammation of the mitral and aortic valves if left untreated. Rheumatic Heart Disease causes an acute generalized inflammatory response and an illness that affects certainly parts of the body mainly Heart, Joints, Brain and skin, Patients with Rheumatic Heart Disease are often severally unwell and they are in great pain and require Hospitalisation. Despite of that it has been postulated streptococcal infection seems to play an important role for clinical presentation shows a streptococcal pharyngitis but streptococcal cellulitis has never been implicated, common feature is a painful migratory arthritis which is present in approximately 80% of patients. There is a link with class-I human leukocyte antigens (HLAs) which has been found. However, evidence which exists suggests that elevated immune complex levels in blood samples from patients with RHD are associated with HLA-B5. Recently it has been estimated that 33.4 million people worldwide have rheumatic heart disease and that 300,000 - 500,000 new cases of rheumatic fever occur annually, with 230,000 deaths resulting from its complications at the same Time at the same time, The World Heart Federation non-communicable disease action plan, developed for the World Health Assembly in 2013, called for a 25% reduction in premature mortality from RHD by the year 2025. This case report discusses about management and prevention of further complications due to rheumatic heart disease.
Keywords: Rheumatic Heart Disease (RHD); Human Leukocyte Antigens (HLAs); Statins Therapy
Citation: Clement Kabakama., et al. “Do Statins Therapy Included as Rationale Treatment and Management for Rheumatic Heart Disease: A Case Report”. Acta Scientific Gastrointestinal Disorders 4.8 (2021): 74-78.
Copyright: © 2021 Clement Kabakama., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.